Preliminary evaluation of urinary soluble Met as a Biomarker for urothelial carcinoma of the bladder Article

McNeil, Brian K, Sorbellini, Maximiliano, Grubb, Robert L et al. (2014). Preliminary evaluation of urinary soluble Met as a Biomarker for urothelial carcinoma of the bladder . Journal of Translational Medicine, 12 10.1186/1479-5876-12-199

Open Access

cited authors

  • McNeil, Brian K; Sorbellini, Maximiliano; Grubb, Robert L; Apolo, Andrea B; Cecchi, Fabiola; Athauda, Gagani; Cohen, Benjamin; Giubellino, Alessio; Simpson, Haley; Agarwal, Piyush K; Coleman, Jonathan; Getzenberg, Robert H; Netto, George J; Shih, Joanna; Linehan, W Marston; Pinto, Peter A; Bottaro, Donald P

sustainable development goals

authors

publication date

  • October 21, 2014

published in

keywords

  • Biomarker
  • Bladder cancer
  • C-MET
  • CANCER
  • CELLS
  • DIAGNOSIS
  • FOLLOW-UP
  • GROWTH-FACTOR
  • HGF receptor
  • HGF/MET SIGNALING PATHWAY
  • Life Sciences & Biomedicine
  • Medicine, Research & Experimental
  • Met
  • Research & Experimental Medicine
  • SURVIVAL
  • Science & Technology
  • Urine
  • Urothelial carcinoma

Digital Object Identifier (DOI)

publisher

  • BIOMED CENTRAL LTD

volume

  • 12